Iovance Biotherapeutics Inc. Common Stock vs iShares US Power Infrastructure ETF — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.63 (market cap $6.04B), while iShares US Power Infrastructure ETF trades at $25.44 (market cap $446.54M). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 13.5× iShares US Power Infrastructure ETF's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, iShares US Power Infrastructure ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and iShares US Power Infrastructure ETF for 14 Days on average.
| IOVA | POWR | |
|---|---|---|
Market Cap | $6.04B | $446.54M |
Volume | 14,805,993 | 160,852 |
Sector | Health | Sector/Thematic |
52-Week High | $14.82 | $28.22 |
52-Week Low | $1.81 | $23.20 |
Typical Hold Time | 0 Days | 14 Days |
Enterprise Value | $5.97B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →iShares U.S. Power Infrastructure ETF seeks exposure to U.S. companies involved in power infrastructure. Its holdings may include electric utilities, transmission and distribution businesses, and electrical equipment providers.
Read more on POWR →